VALERIE CRAWFORD: Open Payments
NPI 1942661434 · TEXARKANA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$763 in 40 payments from 7 companies in 2025. Trend: 2023 $1,554 · 2024 $1,028 · 2025 $763
Food & beverage: $763
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $219 |
| AstraZeneca Pharmaceuticals LP | 11 | $204 |
| GlaxoSmithKline, LLC. | 11 | $160 |
| Lilly USA, LLC | 1 | $104 |
| ABBVIE INC. | 2 | $33 |
| PFIZER INC. | 2 | $32 |
| Phathom Pharmaceuticals, Inc. | 1 | $11 |
Products named: AIRSUPRA, TRELEGY ELLIPTA, ZEPBOUND, Ozempic, Rybelsus, Wegovy, QULIPTA, BREZTRI.
Industry payments across TX — which companies pay providers there.
